annual EBITDA:
-$146.31M+$42.96M(+22.70%)Summary
- As of today (May 29, 2025), ADPT annual EBITDA is -$146.31 million, with the most recent change of +$42.96 million (+22.70%) on December 31, 2024.
- During the last 3 years, ADPT annual EBITDA has risen by +$47.03 million (+24.33%).
- ADPT annual EBITDA is now -286.67% below its all-time high of -$37.84 million, reached on December 31, 2017.
Performance
ADPT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$22.19M+$4.12M(+15.67%)Summary
- As of today (May 29, 2025), ADPT quarterly EBITDA is -$22.19 million, with the most recent change of +$4.12 million (+15.67%) on March 31, 2025.
- Over the past year, ADPT quarterly EBITDA has increased by +$17.13 million (+43.56%).
- ADPT quarterly EBITDA is now -188.38% below its all-time high of -$7.70 million, reached on September 30, 2018.
Performance
ADPT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$111.63M+$17.13M(+13.31%)Summary
- As of today (May 29, 2025), ADPT TTM EBITDA is -$111.63 million, with the most recent change of +$17.13 million (+13.31%) on March 31, 2025.
- Over the past year, ADPT TTM EBITDA has increased by +$68.23 million (+37.93%).
- ADPT TTM EBITDA is now -855.14% below its all-time high of -$11.69 million, reached on March 31, 2018.
Performance
ADPT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ADPT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.7% | +43.6% | +37.9% |
| 3 y3 years | +24.3% | +61.6% | +47.7% |
| 5 y5 years | -107.2% | +32.0% | -31.4% |
ADPT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.3% | at high | +63.6% | at high | +47.7% |
| 5 y | 5-year | -107.2% | +24.3% | at high | +63.6% | -31.4% | +47.7% |
| alltime | all time | -286.7% | +24.3% | -188.4% | +63.6% | -855.1% | +47.7% |
ADPT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$22.19M(-15.7%) | -$111.63M(-13.3%) |
| Dec 2024 | -$146.31M(-22.7%) | -$26.32M(+7.1%) | -$128.76M(-21.3%) |
| Sep 2024 | - | -$24.57M(-36.3%) | -$163.50M(-9.1%) |
| Jun 2024 | - | -$38.55M(-2.0%) | -$179.85M(-0.0%) |
| Mar 2024 | - | -$39.33M(-35.6%) | -$179.85M(-5.0%) |
| Dec 2023 | -$189.27M(+8.0%) | -$61.06M(+49.3%) | -$189.27M(+18.7%) |
| Sep 2023 | - | -$40.91M(+6.1%) | -$159.51M(+1.0%) |
| Jun 2023 | - | -$38.55M(-20.9%) | -$157.88M(-5.0%) |
| Mar 2023 | - | -$48.75M(+55.7%) | -$166.22M(-5.1%) |
| Dec 2022 | -$175.21M(-9.4%) | -$31.30M(-20.3%) | -$175.21M(-12.6%) |
| Sep 2022 | - | -$39.28M(-16.2%) | -$200.42M(-6.2%) |
| Jun 2022 | - | -$46.89M(-18.8%) | -$213.61M(+0.0%) |
| Mar 2022 | - | -$57.74M(+2.2%) | -$213.58M(+9.8%) |
| Dec 2021 | -$193.34M | -$56.51M(+7.7%) | -$194.45M(+8.1%) |
| Sep 2021 | - | -$52.47M(+12.0%) | -$179.83M(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$46.86M(+21.4%) | -$162.26M(+7.9%) |
| Mar 2021 | - | -$38.61M(-7.8%) | -$150.31M(+4.1%) |
| Dec 2020 | -$144.34M(+104.5%) | -$41.89M(+20.0%) | -$144.34M(+15.9%) |
| Sep 2020 | - | -$34.91M(-0.0%) | -$124.57M(+17.9%) |
| Jun 2020 | - | -$34.91M(+7.0%) | -$105.66M(+24.3%) |
| Mar 2020 | - | -$32.64M(+47.6%) | -$84.98M(+20.4%) |
| Dec 2019 | -$70.60M(+61.3%) | -$22.11M(+38.3%) | -$70.60M(+15.7%) |
| Sep 2019 | - | -$15.99M(+12.3%) | -$61.04M(+15.7%) |
| Jun 2019 | - | -$14.23M(-22.1%) | -$52.74M(+4.8%) |
| Mar 2019 | - | -$18.26M(+45.5%) | -$50.33M(+15.0%) |
| Dec 2018 | -$43.76M(+15.6%) | -$12.55M(+63.1%) | -$43.76M(+40.2%) |
| Sep 2018 | - | -$7.70M(-34.9%) | -$31.20M(+32.7%) |
| Jun 2018 | - | -$11.82M(+1.2%) | -$23.51M(+101.2%) |
| Mar 2018 | - | -$11.69M | -$11.69M |
| Dec 2017 | -$37.84M | - | - |
FAQ
- What is Adaptive Biotechnologies annual EBITDA?
- What is the all time high annual EBITDA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual EBITDA year-on-year change?
- What is Adaptive Biotechnologies quarterly EBITDA?
- What is the all time high quarterly EBITDA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly EBITDA year-on-year change?
- What is Adaptive Biotechnologies TTM EBITDA?
- What is the all time high TTM EBITDA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM EBITDA year-on-year change?
What is Adaptive Biotechnologies annual EBITDA?
The current annual EBITDA of ADPT is -$146.31M
What is the all time high annual EBITDA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual EBITDA is -$37.84M
What is Adaptive Biotechnologies annual EBITDA year-on-year change?
Over the past year, ADPT annual EBITDA has changed by +$42.96M (+22.70%)
What is Adaptive Biotechnologies quarterly EBITDA?
The current quarterly EBITDA of ADPT is -$22.19M
What is the all time high quarterly EBITDA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly EBITDA is -$7.70M
What is Adaptive Biotechnologies quarterly EBITDA year-on-year change?
Over the past year, ADPT quarterly EBITDA has changed by +$17.13M (+43.56%)
What is Adaptive Biotechnologies TTM EBITDA?
The current TTM EBITDA of ADPT is -$111.63M
What is the all time high TTM EBITDA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM EBITDA is -$11.69M
What is Adaptive Biotechnologies TTM EBITDA year-on-year change?
Over the past year, ADPT TTM EBITDA has changed by +$68.23M (+37.93%)